The New Process Validation Paradigm - Ispe Bost... Apr 2026

The new paradigm is structured into three distinct stages that move away from static documentation toward continuous learning:

The New Process Validation Paradigm represents a move toward a more "proactive" pharmaceutical quality system. By treating validation as an ongoing journey rather than a destination, the industry ensures a more reliable supply of safe, effective medicines for patients. The New Process Validation Paradigm - ISPE Bost...

This stage replaces the rigid "three-batch" rule. Instead, the number of batches is determined by risk assessment and statistical confidence. It confirms that the process design is capable of reproducible commercial manufacturing. The new paradigm is structured into three distinct

It aligns with ICH Q8, Q9, and Q10 guidelines, facilitating smoother inspections and global compliance. Conclusion Instead, the number of batches is determined by

The focus here is on building a deep understanding of the product and process. By identifying Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) early on, manufacturers can establish a "Design Space" where quality is guaranteed through scientific rationale rather than luck.